Publication Date
| In 2025 | 0 |
| Since 2024 | 1 |
| Since 2021 (last 5 years) | 1 |
| Since 2016 (last 10 years) | 2 |
| Since 2006 (last 20 years) | 2 |
Descriptor
| Behavior Change | 2 |
| Behavior Disorders | 2 |
| Academic Ability | 1 |
| Behavior Patterns | 1 |
| Best Practices | 1 |
| Burnout | 1 |
| Cognitive Ability | 1 |
| College Students | 1 |
| Criticism | 1 |
| Data Use | 1 |
| Decision Making | 1 |
| More ▼ | |
Source
| Ethics and Education | 1 |
| IGI Global | 1 |
Publication Type
| Books | 1 |
| Collected Works - General | 1 |
| Journal Articles | 1 |
| Opinion Papers | 1 |
Education Level
| Higher Education | 2 |
| Postsecondary Education | 2 |
| Elementary Education | 1 |
| Elementary Secondary Education | 1 |
| Secondary Education | 1 |
Audience
| Teachers | 1 |
Location
Laws, Policies, & Programs
Assessments and Surveys
What Works Clearinghouse Rating
Peer reviewed
Direct linkC. Roch Turner, Editor – IGI Global, 2024
In the aftermath of the COVID-19 upheaval, special education professionals grapple with a seismic surge in student behavioral issues. The challenges are formidable, and the interventions available often fall short of making a meaningful impact. "Best Practices for Behavior Intervention in Special Education" steps in to assist the urgent…
Descriptors: Student Behavior, Intervention, Special Education, Best Practices
Inon, Magen – Ethics and Education, 2019
Research shows that various pharmaceuticals can offer modest cognition enhancing effects for healthy individuals. These finding have caused some academics to support liberal use of pharmacological cognitive enhancement (PCE) in schools and universities. This approach partially arises from arguments implying there is little moral justification for…
Descriptors: Pharmacology, Drug Use, Cognitive Ability, Moral Values
